GlassScriptPhysician profile
Leon C Lahaye
NPI 1154318343
$2,399.80
in general payments reported to CMS, 2019-2025
16 companies · $865 in 2025
The $865 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $117 · 2021: $392 · 2022: $222 · 2023: $446 · 2024: $113 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $606.09 | 2022-2025 | Hydrus Microstent, Tryptyr, Voyager Dslt |
| Biotissue Holdings INC. | $380.83 | 2025 | |
| Glaukos Corporation | $255.64 | 2021-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $181.81 | 2023-2025 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.76 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $128.62 | 2019 | |
| Abbvie INC. | $127.16 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $121.78 | 2021 | |
| Ocular Therapeutix, INC. | $117.18 | 2020 | |
| Allergan, INC. | $113.56 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $83.46 | 2023-2024 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Apellis Pharmaceuticals, INC. | $48.07 | 2023 | |
| Dompe US, INC. | $28.00 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $21.82 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $21.01 | 2024 | Xdemvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Lahaye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.